Aseyev, O.; Zrielykh, L.; Shi, M.; Filipovic, K.; Seymour, C.; Siddiqui, R.; Biman, B.
Immune Checkpoint Inhibitor-Induced Pneumonitis in Non-Small Cell Lung Cancer: A Narrative Review of Incidence and Clinical Risk Factors. Curr. Oncol. 2026, 33, 240.
https://doi.org/10.3390/curroncol33050240
AMA Style
Aseyev O, Zrielykh L, Shi M, Filipovic K, Seymour C, Siddiqui R, Biman B.
Immune Checkpoint Inhibitor-Induced Pneumonitis in Non-Small Cell Lung Cancer: A Narrative Review of Incidence and Clinical Risk Factors. Current Oncology. 2026; 33(5):240.
https://doi.org/10.3390/curroncol33050240
Chicago/Turabian Style
Aseyev, Olexiy, Liliia Zrielykh, Minghan Shi, Katherine Filipovic, Claire Seymour, Rabail Siddiqui, and Birubi Biman.
2026. "Immune Checkpoint Inhibitor-Induced Pneumonitis in Non-Small Cell Lung Cancer: A Narrative Review of Incidence and Clinical Risk Factors" Current Oncology 33, no. 5: 240.
https://doi.org/10.3390/curroncol33050240
APA Style
Aseyev, O., Zrielykh, L., Shi, M., Filipovic, K., Seymour, C., Siddiqui, R., & Biman, B.
(2026). Immune Checkpoint Inhibitor-Induced Pneumonitis in Non-Small Cell Lung Cancer: A Narrative Review of Incidence and Clinical Risk Factors. Current Oncology, 33(5), 240.
https://doi.org/10.3390/curroncol33050240
